1.
Al-Zebeeby A, Vogler M, Milani M, Richards C, Alotibi A, Greaves G, Dyer MJ, Cohen GM, Varadarajan S. Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies. Haematologica [Internet]. 2019Apr.30 [cited 2026Nov.6];104(5):1016-25. Available from: https://haematologica.org/article/view/8877